newsfilter
← Latest News
Business Wire·

Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update

Cerus' Notified Body, TÜV-SÜD, has completed the review of the clinical module for the CE Mark submission for INTERCEPT Red Blood Cells (RBCs) Cerus Corporation (NASDAQ:CERS) announced today a European regulatory